Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2012, v. 4, n. 5, p. 315, doi. 10.1177/1759720X12455959
- By:
- Publication type:
- Article
Works matching IS 1759720X AND DT 2012 AND VI 4 AND IP 5
Results: 5
1
2
Novel approaches in the treatment of myositis and myopathies.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2012, v. 4, n. 5, p. 369, doi. 10.1177/1759720X12447705
- By:
- Publication type:
- Article
3
DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2012, v. 4, n. 5, p. 327, doi. 10.1177/1759720X12444710
- By:
- Publication type:
- Article
4
Role of diagnostic ultrasound in the assessment of musculoskeletal diseases.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2012, v. 4, n. 5, p. 341, doi. 10.1177/1759720X12442112
- By:
- Publication type:
- Article
5
Bone disease in primary hyperparathyrodism.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2012, v. 4, n. 5, p. 357, doi. 10.1177/1759720X12441869
- By:
- Publication type:
- Article